CareDx Inc (CDNA)
:CDNA
US Market
Advertisement

CareDx (CDNA) Ratios

Compare
824 Followers

CareDx Ratios

CDNA's free cash flow for Q3 2025 was $0.00. For the 2025 fiscal year, CDNA's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.03 4.02 5.10 5.61 3.95
Quick Ratio
2.75 3.77 4.85 5.38 3.80
Cash Ratio
0.92 1.05 1.18 4.51 1.95
Solvency Ratio
0.62 -0.83 -0.54 -0.19 -0.10
Operating Cash Flow Ratio
0.43 -0.24 -0.33 -0.25 0.48
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 179.11M$ 108.22M$ 275.77M$ 332.62M$ 182.26M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.07 0.07 0.03 0.04
Debt-to-Equity Ratio
0.07 0.13 0.09 0.04 0.06
Debt-to-Capital Ratio
0.06 0.12 0.08 0.04 0.05
Long-Term Debt-to-Capital Ratio
0.06 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.79 1.26 1.22 1.33
Debt Service Coverage Ratio
0.00 0.00 -16.38 0.00 -33.84
Interest Coverage Ratio
0.00 0.00 -20.53 0.00 -65.37
Debt to Market Cap
0.03 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.40 0.64 0.80 0.33 0.35
Net Debt to EBITDA
3.11 0.54 0.83 18.56 11.62
Profitability Margins
Gross Profit Margin
48.06%63.61%65.13%67.14%67.16%
EBIT Margin
-10.86%-37.36%-24.00%-10.03%-10.28%
EBITDA Margin
-6.30%-31.98%-19.03%-6.02%-5.31%
Operating Profit Margin
14.05%-72.55%-24.00%-10.03%-9.22%
Pretax Profit Margin
17.00%-67.83%-23.69%-10.83%-10.28%
Net Profit Margin
16.97%-67.88%-23.81%-10.34%-9.74%
Continuous Operations Profit Margin
16.51%-67.88%-23.81%-10.34%-9.74%
Net Income Per EBT
99.84%100.07%100.50%95.56%94.75%
EBT Per EBIT
120.99%93.50%98.71%107.95%111.49%
Return on Assets (ROA)
14.06%-40.76%-14.11%-5.41%-5.08%
Return on Equity (ROE)
17.41%-72.81%-17.78%-6.58%-6.74%
Return on Capital Employed (ROCE)
15.09%-52.31%-16.54%-6.07%-5.92%
Return on Invested Capital (ROIC)
15.15%-49.34%-16.42%-5.76%-5.57%
Return on Tangible Assets
16.95%-49.97%-16.57%-6.40%-6.23%
Earnings Yield
7.41%-29.49%-12.59%-1.29%-0.56%
Efficiency Ratios
Receivables Turnover
7.48 5.49 4.85 4.96 5.55
Payables Turnover
7.41 7.92 11.29 7.30 6.54
Inventory Turnover
3.03 5.24 5.83 5.67 6.30
Fixed Asset Turnover
6.52 4.30 4.58 7.40 7.41
Asset Turnover
0.83 0.60 0.59 0.52 0.52
Working Capital Turnover Ratio
1.72 1.02 0.96 1.06 1.60
Cash Conversion Cycle
119.87 90.10 105.43 88.02 67.83
Days of Sales Outstanding
48.78 66.48 75.22 73.59 65.76
Days of Inventory Outstanding
120.37 69.68 62.56 64.41 57.90
Days of Payables Outstanding
49.28 46.06 32.34 49.99 55.82
Operating Cycle
169.15 136.16 137.77 138.00 123.65
Cash Flow Ratios
Operating Cash Flow Per Share
0.81 -0.34 -0.47 -0.37 0.72
Free Cash Flow Per Share
0.78 -0.51 -0.93 -0.76 0.50
CapEx Per Share
0.05 0.17 0.46 0.39 0.22
Free Cash Flow to Operating Cash Flow
0.96 1.50 1.96 2.05 0.69
Dividend Paid and CapEx Coverage Ratio
16.83 -1.99 -1.04 -0.95 3.23
Capital Expenditure Coverage Ratio
16.83 -1.99 -1.04 -0.95 3.23
Operating Cash Flow Coverage Ratio
2.01 -0.54 -0.65 -1.11 2.08
Operating Cash Flow to Sales Ratio
0.12 -0.07 -0.08 -0.07 0.17
Free Cash Flow Yield
5.11%-4.28%-8.15%-1.66%0.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.50 -3.39 -7.94 -77.49 -179.95
Price-to-Sales (P/S) Ratio
2.24 2.30 1.89 8.02 17.52
Price-to-Book (P/B) Ratio
2.64 2.47 1.41 5.10 12.13
Price-to-Free Cash Flow (P/FCF) Ratio
19.58 -23.35 -12.27 -60.07 145.97
Price-to-Operating Cash Flow Ratio
19.27 -35.09 -24.11 -123.14 100.73
Price-to-Earnings Growth (PEG) Ratio
0.90 -0.02 -0.06 -1.63 7.80
Price-to-Fair Value
2.64 2.47 1.41 5.10 12.13
Enterprise Value Multiple
-32.51 -6.66 -9.11 -114.61 -318.34
Enterprise Value
733.19M 597.20M 557.48M 2.04B 3.25B
EV to EBITDA
-32.51 -6.66 -9.11 -114.61 -318.34
EV to Sales
2.05 2.13 1.73 6.90 16.90
EV to Free Cash Flow
17.87 -21.62 -11.25 -51.70 140.83
EV to Operating Cash Flow
17.23 -32.48 -22.09 -105.98 97.19
Tangible Book Value Per Share
4.52 3.26 6.57 7.25 4.51
Shareholders’ Equity Per Share
5.93 4.86 8.08 8.92 5.97
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 0.04 0.05
Revenue Per Share
6.82 5.21 6.03 5.67 4.13
Net Income Per Share
1.16 -3.54 -1.44 -0.59 -0.40
Tax Burden
1.00 1.00 1.00 0.96 0.95
Interest Burden
-1.57 1.82 0.99 1.08 1.00
Research & Development to Revenue
0.19 0.29 0.28 0.26 0.25
SG&A to Revenue
0.33 0.42 0.31 0.25 0.25
Stock-Based Compensation to Revenue
0.15 0.18 0.14 0.12 0.12
Income Quality
0.70 0.10 0.33 0.63 -1.79
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis